Nirvana Life Sciences Inc. (CSE:NIRV)
Canada · Delayed Price · Currency is CAD 0.0800
-0.0200 (-20.00%)
Jul 29, 2025, 9:05 AM EDT
Accolade Market Cap
Nirvana Life Sciences has a market cap or net worth of CAD 385.86 thousand as of August 12, 2025. Its market cap has decreased by -83.11% in one year.
Market Cap
385.86K
Enterprise Value
476.63K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since March 17, 2022, Nirvana Life Sciences's market cap has decreased from 4.27M to 385.86K, a decrease of -90.96%. That is a compound annual growth rate of -51.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 385.86K | -84.00% |
| Dec 27, 2024 | 2.41M | 150.00% |
| Dec 28, 2023 | 964.66K | -81.10% |
| Dec 19, 2022 | 5.10M | 19.58% |
| Mar 17, 2022 | 4.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.28B |
| Curaleaf Holdings | 2.14B |
| Sienna Senior Living | 1.72B |
| dentalcorp Holdings | 1.63B |
| Trulieve Cannabis | 1.51B |
| WELL Health Technologies | 1.24B |
| Cronos Group | 1.22B |
| Extendicare | 1.10B |